Molecular testing provides fast and accurate results and the prescence of molecular tests has disrupted several testing markets over the past decade and a half. However, some segments have thrived and others are seeing mature growth levels.
This report details the highest revenue growth areas of molecular testing, as considered by manufacturers of IVD instruments, reagents and supplies. The report covers both high-growth product segments and regional markets of significance.
In 2017, the global Molecular Blood market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.
This report focuses on the global Molecular Blood status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Molecular Blood development in United States, Europe and China.
This report details the highest revenue growth areas of molecular testing, as considered by manufacturers of IVD instruments, reagents and supplies. The report covers both high-growth product segments and regional markets of significance.
In 2017, the global Molecular Blood market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.
This report focuses on the global Molecular Blood status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Molecular Blood development in United States, Europe and China.
The key players covered in this study
Abbott Laboratories
QIAGEN
Roche Diagnostics
Hologic
Grifols
Siemens Healthcare
Becton, Dickinson
Danaher
Biomerieux
Cepheid
Abbott Laboratories
QIAGEN
Roche Diagnostics
Hologic
Grifols
Siemens Healthcare
Becton, Dickinson
Danaher
Biomerieux
Cepheid
Request For Sample Report @ https://www.wiseguyreports.com/sample-request/3461486-global-molecular-blood-market-size-status-and-forecast-2018-2025
Market segment by Type, the product can be split into
PCR
PCR-RFLP
AS-PCR or PCR-SSP
Multiplex PCR
Real Time PCR
Sanger DNA Sequencing
Pyrosequencing
PCR
PCR-RFLP
AS-PCR or PCR-SSP
Multiplex PCR
Real Time PCR
Sanger DNA Sequencing
Pyrosequencing
Market segment by Application, split into
Blood Centers
Plasma Fractionation Facilities
Hospitals
Commercial/Private Laboratories
Military Blood Banks
Blood Centers
Plasma Fractionation Facilities
Hospitals
Commercial/Private Laboratories
Military Blood Banks
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:To analyze global Molecular Blood status, future forecast, growth opportunity, key market and key players.
To present the Molecular Blood development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
To present the Molecular Blood development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
Complete Report Details @ https://www.wiseguyreports.com/reports/3461486-global-molecular-blood-market-size-status-and-forecast-2018-2025
Table Of Contents:
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type1.4.1 Global Molecular Blood Market Size Growth Rate by Type (2013-2025)
1.4.2 PCR
1.4.3 PCR-RFLP
1.4.4 AS-PCR or PCR-SSP
1.4.5 Multiplex PCR
1.4.6 Real Time PCR
1.4.7 Sanger DNA Sequencing
1.4.8 Pyrosequencing
1.5 Market by Application1.5.1 Global Molecular Blood Market Share by Application (2013-2025)
1.5.2 Blood Centers
1.5.3 Plasma Fractionation Facilities
1.5.4 Hospitals
1.5.5 Commercial/Private Laboratories
1.5.6 Military Blood Banks
1.6 Study Objectives
1.7 Years Considered
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type1.4.1 Global Molecular Blood Market Size Growth Rate by Type (2013-2025)
1.4.2 PCR
1.4.3 PCR-RFLP
1.4.4 AS-PCR or PCR-SSP
1.4.5 Multiplex PCR
1.4.6 Real Time PCR
1.4.7 Sanger DNA Sequencing
1.4.8 Pyrosequencing
1.5 Market by Application1.5.1 Global Molecular Blood Market Share by Application (2013-2025)
1.5.2 Blood Centers
1.5.3 Plasma Fractionation Facilities
1.5.4 Hospitals
1.5.5 Commercial/Private Laboratories
1.5.6 Military Blood Banks
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends2.1 Molecular Blood Market Size
2.2 Molecular Blood Growth Trends by Regions
2.2.1 Molecular Blood Market Size by Regions (2013-2025)
2.2.2 Molecular Blood Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
2.2 Molecular Blood Growth Trends by Regions
2.2.1 Molecular Blood Market Size by Regions (2013-2025)
2.2.2 Molecular Blood Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
…..
12 International Players Profiles
12.1 Abbott Laboratories12.1.1 Abbott Laboratories Company Details
12.1.2 Company Description and Business Overview
12.1.3 Molecular Blood Introduction
12.1.4 Abbott Laboratories Revenue in Molecular Blood Business (2013-2018)
12.1.5 Abbott Laboratories Recent Development
12.2 QIAGEN12.2.1 QIAGEN Company Details
12.2.2 Company Description and Business Overview
12.2.3 Molecular Blood Introduction
12.2.4 QIAGEN Revenue in Molecular Blood Business (2013-2018)
12.2.5 QIAGEN Recent Development
12.3 Roche Diagnostics12.3.1 Roche Diagnostics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Molecular Blood Introduction
12.3.4 Roche Diagnostics Revenue in Molecular Blood Business (2013-2018)
12.3.5 Roche Diagnostics Recent Development
12.4 Hologic12.4.1 Hologic Company Details
12.4.2 Company Description and Business Overview
12.4.3 Molecular Blood Introduction
12.4.4 Hologic Revenue in Molecular Blood Business (2013-2018)
12.4.5 Hologic Recent Development
12.5 Grifols12.5.1 Grifols Company Details
12.5.2 Company Description and Business Overview
12.5.3 Molecular Blood Introduction
12.5.4 Grifols Revenue in Molecular Blood Business (2013-2018)
12.5.5 Grifols Recent Development
12.1 Abbott Laboratories12.1.1 Abbott Laboratories Company Details
12.1.2 Company Description and Business Overview
12.1.3 Molecular Blood Introduction
12.1.4 Abbott Laboratories Revenue in Molecular Blood Business (2013-2018)
12.1.5 Abbott Laboratories Recent Development
12.2 QIAGEN12.2.1 QIAGEN Company Details
12.2.2 Company Description and Business Overview
12.2.3 Molecular Blood Introduction
12.2.4 QIAGEN Revenue in Molecular Blood Business (2013-2018)
12.2.5 QIAGEN Recent Development
12.3 Roche Diagnostics12.3.1 Roche Diagnostics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Molecular Blood Introduction
12.3.4 Roche Diagnostics Revenue in Molecular Blood Business (2013-2018)
12.3.5 Roche Diagnostics Recent Development
12.4 Hologic12.4.1 Hologic Company Details
12.4.2 Company Description and Business Overview
12.4.3 Molecular Blood Introduction
12.4.4 Hologic Revenue in Molecular Blood Business (2013-2018)
12.4.5 Hologic Recent Development
12.5 Grifols12.5.1 Grifols Company Details
12.5.2 Company Description and Business Overview
12.5.3 Molecular Blood Introduction
12.5.4 Grifols Revenue in Molecular Blood Business (2013-2018)
12.5.5 Grifols Recent Development
Continued…….
CONTACT US:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
No comments:
Post a Comment